CYCLOSPORIN A
Nonmalignant Neoplasm
University of Nebraskaprotein_peptidePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Nonmalignant Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ringer's acetate Joachim Zdolsek | Phase 4 | BB |
NORMAL HUMAN SERUM ALBUMIN Joachim Zdolsek | Phase 4 | BB |
ETOPOSIDE Roswell Park Cancer Institute | Phase 2/3 | B |
Cyclophosphamide Roswell Park Cancer Institute | Phase 2/3 | B |
Thiotepa Roswell Park Cancer Institute | Phase 2/3 | B |
View all 16 →
Same molecule, other indications
CYCLOSPORIN A is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →